August 2008 Issue of MMM
It's August. Which means the dog days of the media budget-planning season are upon us again.
Pfizer's recent decision to pull the plug on direct funding of CME through independent commercial providers follows months of public criticism of pharma support. Lew ...
There hasn't been much good news for providers in the past year, according to MM&M's annual Medical Education Survey, with regulatory issues squeezing budgets hard. ...
Some of the best-known media directors in medical marketing assembled at the offices of MM&M to discuss the media issues of the day—and to offer ...
Social networks and an expanded digital landscape have opened up more avenues for pharmaceutical and healthcare marketers to reach their patient and physician customers. Deborah ...
Craig Millian left Pfizer, where he was the US commercial lead for Lipitor, for Vertex Pharmaceuticals in January 2006.
As I write this, I have just returned from The Pharmaceutical Business Intelligence and Research Group annual general meeting in Washington, DC.
Regular readers of this column know that one of my major themes is to defend lifesaving effective drugs that are wrongly targeted in the media.
Pfizer's announcement that it would no longer support accredited CME programs directly through commercial providers has beleaguered medical education and communication companies (MECCs) scrambling.
Med Ed Report
Pfizer will no longer fund continuing medical education through med ed firms.
The chairman of the Senate Committee on Aging has written the Accreditation Council for Continuing Medical Education (ACCME) complaining that GlaxoSmithKline, which makes Valtrex, "sponsors ...
CBS Evening News and BusinessWeek collaborated on a series titled "Doctors under the influence?," looking at whether speaking and consulting fees paid by pharmas to ...
Coalition for Healthcare Communications responds to IMS vs. Vermont with amicus brief.
In a scathing rebuke to its assessment of conflicts of interest in CME, a trio of accrediting agencies said the Macy Foundation's assertions "reflect concerns ...
Elsevier's OncologySTAT portal has attracted over 12,000 registrants since its September 2007 launch.
Lippincott's Nursing Procedures and Skills has been upgraded to provide hospitals with over 200 pediatric procedures.
The American Association for Cancer Research (AARC) has appointed Diane Scott-Lichter as publisher and head of its scientific publishing division.
Oakstone Publishing has been acquired by private equity firm Boston Ventures.
Merion Publications' ADVANCE Newsmagazines has launched a new ADVANCE for Healthcare Careers website.
A group of 12 publishers, including Elsevier, the American Society of Neuroradiology, JAMA and the Nature Publishing Group, have elected to use new plagiarism detection ...
With fewer big, mass-market brands and pharmaceutical companies seeking cost savings all around, will video-on-demand (VOD) and other more targeted cable advertising vehicles sap spending ...
Healthline Networks, an online healthcare information portal, has launched Healthline Media Networks, offering advertisers vertical, full-network contextual buys.
Using technology to aid ever-diminishing sales forces is not only a good idea, but a necessity, given the decreased opportunities to interact directly with health ...
Contract sales firm PDI has announced that Michael Marquard, CEO and a member of PDI's board of directors, has retired.
ID Media has launched M.O.R.E., a local direct marketing system.
Direct marketing agency Wunderman has acquired Designkitchen, a digital and interactive agency in Chicago.
Williams-Labadie, a division of the Publicis Healthcare Communications Group, has announced the appointment of Frank Bartco to senior account supervisor
All the fury over DTC drug ads emanating from Washington hasn't dented their credibility with consumers, according to Rodale's 11th annual Survey on Consumer Reaction ...
The Federal Trade Commission has opened an investigation into the possible deceptive advertising and marketing of DTC genetic tests, according to The New York Times
Pfizer gathered capabilities info from its US consumer and professional advertising and PR agencies while issuing RFIs to some non-roster agencies, AdWeek reported.
Reps. John Dingell and Bart Stupak, who chair the Committee on Energy and Commerce and the Oversight and Investigations Subcommittee thereof, respectively, praised Merck, Schering-Plough, ...
A report by West Virginia's Pharmaceutical Cost Management Council said pharmas spent $16 million on DTC advertising in the state from July 2007 through December ...
Most companies have not evolved their marketing strategies to keep pace with the magnitude of evolution we're seeing in how physicians gather information to make ...
Microsoft's HealthVault has announced a collaboration deal with communications giant AT&T and computer platform service provider Covisint that will allow patients to share medical information ...
When pharmaceutical companies choose to maintain a favorable and high-profile media presence, the benefits are commercially advantageous, with measurable corporate, investor and marketing and sales ...
Cohn & Wolfe has launched GCI Health, a global public relations firm.
Responding to the billions of dollars in industry fines paid under the False Claims Act, the Center for Communication Compliance (CCC) launched a new online ...
As Baby boomers transition into their 50s and 60s, a once complacent segment of the healthcare market is taking matters into its own hands.
Decision Resources has acquired Manhattan Research.
As a new study finds that pharma has become Washington's largest lobby in terms of dollars spent in campaign contributions, a high-stakes battle is looming ...
While it holds exciting promise for protecting public health, last year's FDA Amendments Act (FDAAA) is actually slowing down new drug approvals, a key agency ...
Sen. Sherrod Brown (D-OH) wants the FDA to evaluate how it protects the American public from drug products containing tainted, outsourced ingredients.
Calling it "a tremendous loss for the agency," FDA commissioner Andrew von Eschenbach announced in June that the impending departure after three years in the ...
In a ruling that provided comfort to drug companies defending dissident former employees' whistleblower suits, the US Supreme Court said in June that False Claims ...
DDMAC responses to queries posed by drug sponsors or manufacturers regarding ad/promo issues may only be regarded as official (for legal purposes) if they are ...
An HHS Office of Inspector General report says the FDA does not approve 96% of new generic drugs reviewed during their first cycle because they ...
The number of new industry-sponsored clinical trial starts went up 12% to a record high in 2007, according to data released by Parexel International Corp.
The initials CEO, CFO and COO have become so ubiquitous that it's no longer necessary to spell out what they stand for. (I hope.)
- Biogen ends Tecfidera DTC campaign, citing prescriptions
- As immuno-oncology therapies evolve, so will the marketing
- GSK Consumer Healthcare to prioritize digital after agency review
- Five things for pharma marketers to know: Thursday, July 21, 2016
- Five things for pharma marketers to know: Tuesday, July 26, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy
- Sponsored Podcast: No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers
- W2O names Gillespie chief strategy officer of medtech practice
- Five things for pharma marketers to know: Wednesday, July 27, 2016
- DigitasLBi's Carlos Ricque on Why Simple Ads Are the Hardest to Make
- Healthcare marketers: Don't forget about the baby boomers